Lactobacillus rhamnosus (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lactobacillus rhamnosus" in Italian language version.

refsWebsite

Global rank Italian rank

38nih.gov

4^th place

9^th place

32doi.org

2^nd place

7^th place

15oadoi.org

799^th place

22^nd place

8archive.org

6^th place

8^th place

2books.google.com

3^rd place

14^th place

1google.com

163^rd place

289^th place

archive.org

(EN) Falkow, Stanley; Dworkin, Martin, The prokaryotes: a handbook on the biology of bacteria, Berlin, Springer, 2006, p. 360, ISBN 0-387-25494-3.
M. Gotteland, S. Cruchet; S. Verbeke, Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans., in Aliment Pharmacol Ther, vol. 15, n. 1, gennaio 2001, pp. 11-7, PMID 11136273.
J. Shen, HZ. Ran; MH. Yin; TX. Zhou; DS. Xiao, Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease., in Intern Med J, vol. 39, n. 2, febbraio 2009, pp. 103-9, DOI:10.1111/j.1445-5994.2008.01791.x, PMID 19220543.
H. Braat, J. van den Brande; E. van Tol; D. Hommes; M. Peppelenbosch; S. van Deventer, Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function., in Am J Clin Nutr, vol. 80, n. 6, dicembre 2004, pp. 1618-25, PMID 15585777.
CE. Bränning, ME. Nyman, Malt in combination with Lactobacillus rhamnosus increases concentrations of butyric acid in the distal colon and serum in rats compared with other barley products but decreases viable counts of cecal bifidobacteria., in J Nutr, vol. 141, n. 1, gennaio 2011, pp. 101-7, DOI:10.3945/jn.110.122226, PMID 21106924.
VT. Do, BG. Baird; DR. Kockler, Probiotics for maintaining remission of ulcerative colitis in adults., in Ann Pharmacother, vol. 44, n. 3, marzo 2010, pp. 565-71, DOI:10.1345/aph.1M498, PMID 20124461.
MP. Gosselink, WR. Schouten; LM. van Lieshout; WC. Hop; JD. Laman; JG. Ruseler-van Embden, Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG., in Dis Colon Rectum, vol. 47, n. 6, giugno 2004, pp. 876-84, DOI:10.1007/s10350-004-0525-z, PMID 15108026.
(EN) Preedy, Victor R. e Watson, Ronald R., Bioactive Foods in Promoting Health: Probiotics and Prebiotics, Boston, Academic Press, 2010, p. 55, ISBN 0-12-374938-7.

books.google.com

Ipek Goktepe, Vijay K. Juneja e Mohamed Ahmedna, Probiotics In Food Safety And Human Health, CRC Press, 10 ottobre 2005, pp. 117–, ISBN 978-1-57444-514-5. URL consultato il 7 luglio 2012.
J.J. Malago, Probiotic Bacteria and Enteric Infections: Cytoprotection by Probiotic Bacteria, Springer, 31 gennaio 2011, pp. 48–, ISBN 978-94-007-0385-8.

doi.org

dx.doi.org

IJ. Claes, G. Schoofs; K. Regulski; P. Courtin; MP. Chapot-Chartier; T. Rolain; P. Hols; I. von Ossowski; J. Reunanen; WM. de Vos; A. Palva, Genetic and biochemical characterization of the cell wall hydrolase activity of the major secreted protein of Lactobacillus rhamnosus GG., in PLoS One, vol. 7, n. 2, 2012, pp. e31588, DOI:10.1371/journal.pone.0031588, PMID 22359601.
R. Korhonen, O. Kosonen; R. Korpela; E. Moilanen, The expression of COX2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells., in Lett Appl Microbiol, vol. 39, n. 1, 2004, pp. 19-24, DOI:10.1111/j.1472-765X.2004.01531.x, PMID 15189283.
A. Klinder, A. Förster; G. Caderni; AP. Femia; BL. Pool-Zobel, Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination., in Nutr Cancer, vol. 49, n. 2, 2004, pp. 144-55, DOI:10.1207/s15327914nc4902_5, PMID 15489207.
M. Lorea Baroja, PV. Kirjavainen; S. Hekmat; G. Reid, Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients., in Clin Exp Immunol, vol. 149, n. 3, settembre 2007, pp. 470-9, DOI:10.1111/j.1365-2249.2007.03434.x, PMID 17590176.
B. Foligne, G. Zoumpopoulou; J. Dewulf; A. Ben Younes; F. Chareyre; JC. Sirard; B. Pot; C. Grangette, A key role of dendritic cells in probiotic functionality., in PLoS One, vol. 2, n. 3, 2007, pp. e313, DOI:10.1371/journal.pone.0000313, PMID 17375199.
A. Pillai, R. Nelson, Probiotics for treatment of Clostridium difficile-associated colitis in adults., in Cochrane Database Syst Rev, n. 1, 2008, pp. CD004611, DOI:10.1002/14651858.CD004611.pub2, PMID 18254055.
PW. Lin, LE. Myers; L. Ray; SC. Song; TR. Nasr; AJ. Berardinelli; K. Kundu; N. Murthy; JM. Hansen; AS. Neish, Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation., in Free Radic Biol Med, vol. 47, n. 8, ottobre 2009, pp. 1205-11, DOI:10.1016/j.freeradbiomed.2009.07.033, PMID 19660542.
E. Mileti, G. Matteoli; ID. Iliev; M. Rescigno, Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy., in PLoS One, vol. 4, n. 9, 2009, pp. e7056, DOI:10.1371/journal.pone.0007056, PMID 19756155.
IJ. Claes, S. Lebeer; C. Shen; TL. Verhoeven; E. Dilissen; G. De Hertogh; DM. Bullens; JL. Ceuppens; G. Van Assche; S. Vermeire; P. Rutgeerts, Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis., in Clin Exp Immunol, vol. 162, n. 2, novembre 2010, pp. 306-14, DOI:10.1111/j.1365-2249.2010.04228.x, PMID 20731672.
D. Jonkers, J. Penders; A. Masclee; M. Pierik, Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients., in Drugs, vol. 72, n. 6, aprile 2012, pp. 803-23, DOI:10.2165/11632710-000000000-00000, PMID 22512365.
J. Shen, HZ. Ran; MH. Yin; TX. Zhou; DS. Xiao, Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease., in Intern Med J, vol. 39, n. 2, febbraio 2009, pp. 103-9, DOI:10.1111/j.1445-5994.2008.01791.x, PMID 19220543.
CE. Bränning, ME. Nyman, Malt in combination with Lactobacillus rhamnosus increases concentrations of butyric acid in the distal colon and serum in rats compared with other barley products but decreases viable counts of cecal bifidobacteria., in J Nutr, vol. 141, n. 1, gennaio 2011, pp. 101-7, DOI:10.3945/jn.110.122226, PMID 21106924.
VT. Do, BG. Baird; DR. Kockler, Probiotics for maintaining remission of ulcerative colitis in adults., in Ann Pharmacother, vol. 44, n. 3, marzo 2010, pp. 565-71, DOI:10.1345/aph.1M498, PMID 20124461.
MP. Gosselink, WR. Schouten; LM. van Lieshout; WC. Hop; JD. Laman; JG. Ruseler-van Embden, Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG., in Dis Colon Rectum, vol. 47, n. 6, giugno 2004, pp. 876-84, DOI:10.1007/s10350-004-0525-z, PMID 15108026.
FK. Ghishan, PR. Kiela, From probiotics to therapeutics: another step forward?, in J Clin Invest, vol. 121, n. 6, giugno 2011, pp. 2149-52, DOI:10.1172/JCI58025, PMID 21606604.
TS. Plantinga, WW. van Maren; J. van Bergenhenegouwen; M. Hameetman; S. Nierkens; C. Jacobs; DJ. de Jong; LA. Joosten; B. van't Land; J. Garssen; GJ. Adema, Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics., in Clin Vaccine Immunol, vol. 18, n. 4, aprile 2011, pp. 621-8, DOI:10.1128/CVI.00498-10, PMID 21288993.
KA. Donato, MG. Gareau; YJ. Wang; PM. Sherman, Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling., in Microbiology, vol. 156, Pt 11, novembre 2010, pp. 3288-97, DOI:10.1099/mic.0.040139-0, PMID 20656777.
AJ. Martins, P. Colquhoun; G. Reid; SO. Kim, Reduced expression of basal and probiotic-inducible G-CSF in intestinal mononuclear cells is associated with inflammatory bowel disease., in Inflamm Bowel Dis, vol. 15, n. 4, aprile 2009, pp. 515-25, DOI:10.1002/ibd.20808, PMID 19058228.
BR. Goldin, SL. Gorbach, Clinical indications for probiotics: an overview., in Clin Infect Dis, 46 Suppl 2, febbraio 2008, pp. S96-100; discussion S144-51, DOI:10.1086/523333, PMID 18181732.
M Del Piano e altri, The innovative potential of Lactobacillus rhamnosus LR06, Lactobacillus pentosus LPS01, Lactobacillus plantarum LP01, and Lactobacillus delbrueckii Subsp. delbrueckii LDD01 to restore the "gastric barrier effect" in patients chronically treated with PPI: a pilot study, in J Clin Gastroenterol, n. 46, DOI:10.1097/MCG.0b013e318267b55d, PMID 22955351.
Roberto Berni Canani, Pia Cirillo e Gianluca Terrin, Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations, in BMJ (Clinical research ed.), vol. 335, n. 7615, 18 agosto 2007, p. 340, DOI:10.1136/bmj.39272.581736.55, PMID 17690340. URL consultato il 17 maggio 2018.
P. Osterlund, T. Ruotsalainen e R. Korpela, Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study, in British Journal of Cancer, vol. 97, n. 8, 22 ottobre 2007, pp. 1028-1034, DOI:10.1038/sj.bjc.6603990, PMID 17895895. URL consultato il 17 maggio 2018.
Iva Hojsak, Valentina Fabiano e Tudor Lucian Pop, Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups, in Acta Paediatrica (Oslo, Norway: 1992), vol. 107, n. 6, 2018-6, pp. 927-937, DOI:10.1111/apa.14270, PMID 29446865. URL consultato il 17 maggio 2018.
Donald Cameron, Quak Seng Hock e Musal Kadim, Probiotics for gastrointestinal disorders: Proposed recommendations for children of the Asia-Pacific region, in World Journal of Gastroenterology, vol. 23, n. 45, 7 dicembre 2017, pp. 7952-7964, DOI:10.3748/wjg.v23.i45.7952, PMID 29259371. URL consultato il 17 maggio 2018.
Sara Blaabjerg, Daniel Maribo Artzi e Rune Aabenhus, Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients-A Systematic Review and Meta-Analysis, in Antibiotics (Basel, Switzerland), vol. 6, n. 4, 12 ottobre 2017, DOI:10.3390/antibiotics6040021, PMID 29023420. URL consultato il 17 maggio 2018.
Saif Ul Islam, Clinical Uses of Probiotics, in Medicine, vol. 95, n. 5, 2016-2, pp. e2658, DOI:10.1097/MD.0000000000002658, PMID 26844491. URL consultato il 17 maggio 2018.
R. J. Boyle, F. J. Bath-Hextall e J. Leonardi-Bee, Probiotics for the treatment of eczema: a systematic review, in Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology, vol. 39, n. 8, 2009-8, pp. 1117-1127, DOI:10.1111/j.1365-2222.2009.03305.x. URL consultato il 17 maggio 2018.
Marko Kalliomäki, Seppo Salminen e Tuija Poussa, Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial, in The Journal of Allergy and Clinical Immunology, vol. 119, n. 4, 2007-4, pp. 1019-1021, DOI:10.1016/j.jaci.2006.12.608. URL consultato il 17 maggio 2018.
M. Kalliomäki, S. Salminen e H. Arvilommi, Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial, in Lancet (London, England), vol. 357, n. 9262, 7 aprile 2001, pp. 1076-1079, DOI:10.1016/S0140-6736(00)04259-8, PMID 11297958.
A. Avlami, T. Kordossis e N. Vrizidis, Lactobacillus rhamnosus endocarditis complicating colonoscopy, in The Journal of Infection, vol. 42, n. 4, 2001-5, pp. 283-285, DOI:10.1053/jinf.2001.0793. URL consultato il 17 maggio 2018.
V. Gupta e R. Garg, Probiotics, in Indian Journal of Medical Microbiology, vol. 27, n. 3, 2009-7, pp. 202-209, DOI:10.4103/0255-0857.53201, PMID 19584499. URL consultato il 17 maggio 2018.
Minna K. Salminen, Soile Tynkkynen e Hilpi Rautelin, Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland, in Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, vol. 35, n. 10, 15 novembre 2002, pp. 1155-1160, DOI:10.1086/342912. URL consultato il 17 maggio 2018.

google.com

(EN) Patent US4839281 - Lactobacillus strains and methods of selection - Google Patents, su google.com. URL consultato il 7 luglio 2012.

nih.gov

ncbi.nlm.nih.gov

IJ. Claes, G. Schoofs; K. Regulski; P. Courtin; MP. Chapot-Chartier; T. Rolain; P. Hols; I. von Ossowski; J. Reunanen; WM. de Vos; A. Palva, Genetic and biochemical characterization of the cell wall hydrolase activity of the major secreted protein of Lactobacillus rhamnosus GG., in PLoS One, vol. 7, n. 2, 2012, pp. e31588, DOI:10.1371/journal.pone.0031588, PMID 22359601.
M. Gotteland, S. Cruchet; S. Verbeke, Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans., in Aliment Pharmacol Ther, vol. 15, n. 1, gennaio 2001, pp. 11-7, PMID 11136273.
R. Korhonen, O. Kosonen; R. Korpela; E. Moilanen, The expression of COX2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells., in Lett Appl Microbiol, vol. 39, n. 1, 2004, pp. 19-24, DOI:10.1111/j.1472-765X.2004.01531.x, PMID 15189283.
A. Klinder, A. Förster; G. Caderni; AP. Femia; BL. Pool-Zobel, Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination., in Nutr Cancer, vol. 49, n. 2, 2004, pp. 144-55, DOI:10.1207/s15327914nc4902_5, PMID 15489207.
M. Lorea Baroja, PV. Kirjavainen; S. Hekmat; G. Reid, Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients., in Clin Exp Immunol, vol. 149, n. 3, settembre 2007, pp. 470-9, DOI:10.1111/j.1365-2249.2007.03434.x, PMID 17590176.
B. Foligne, G. Zoumpopoulou; J. Dewulf; A. Ben Younes; F. Chareyre; JC. Sirard; B. Pot; C. Grangette, A key role of dendritic cells in probiotic functionality., in PLoS One, vol. 2, n. 3, 2007, pp. e313, DOI:10.1371/journal.pone.0000313, PMID 17375199.
A. Pillai, R. Nelson, Probiotics for treatment of Clostridium difficile-associated colitis in adults., in Cochrane Database Syst Rev, n. 1, 2008, pp. CD004611, DOI:10.1002/14651858.CD004611.pub2, PMID 18254055.
PW. Lin, LE. Myers; L. Ray; SC. Song; TR. Nasr; AJ. Berardinelli; K. Kundu; N. Murthy; JM. Hansen; AS. Neish, Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation., in Free Radic Biol Med, vol. 47, n. 8, ottobre 2009, pp. 1205-11, DOI:10.1016/j.freeradbiomed.2009.07.033, PMID 19660542.
E. Mileti, G. Matteoli; ID. Iliev; M. Rescigno, Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy., in PLoS One, vol. 4, n. 9, 2009, pp. e7056, DOI:10.1371/journal.pone.0007056, PMID 19756155.
IJ. Claes, S. Lebeer; C. Shen; TL. Verhoeven; E. Dilissen; G. De Hertogh; DM. Bullens; JL. Ceuppens; G. Van Assche; S. Vermeire; P. Rutgeerts, Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis., in Clin Exp Immunol, vol. 162, n. 2, novembre 2010, pp. 306-14, DOI:10.1111/j.1365-2249.2010.04228.x, PMID 20731672.
D. Jonkers, J. Penders; A. Masclee; M. Pierik, Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients., in Drugs, vol. 72, n. 6, aprile 2012, pp. 803-23, DOI:10.2165/11632710-000000000-00000, PMID 22512365.
J. Shen, HZ. Ran; MH. Yin; TX. Zhou; DS. Xiao, Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease., in Intern Med J, vol. 39, n. 2, febbraio 2009, pp. 103-9, DOI:10.1111/j.1445-5994.2008.01791.x, PMID 19220543.
A. Bousvaros, S. Guandalini; RN. Baldassano; C. Botelho; J. Evans; GD. Ferry; B. Goldin; L. Hartigan; S. Kugathasan; J. Levy; KF. Murray, A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease., in Inflamm Bowel Dis, vol. 11, n. 9, settembre 2005, pp. 833-9, PMID 16116318.
H. Braat, J. van den Brande; E. van Tol; D. Hommes; M. Peppelenbosch; S. van Deventer, Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function., in Am J Clin Nutr, vol. 80, n. 6, dicembre 2004, pp. 1618-25, PMID 15585777.
C. Prantera, ML. Scribano, Probiotics and Crohn's disease., in Dig Liver Dis, 34 Suppl 2, settembre 2002, pp. S66-7, PMID 12408444.
CE. Bränning, ME. Nyman, Malt in combination with Lactobacillus rhamnosus increases concentrations of butyric acid in the distal colon and serum in rats compared with other barley products but decreases viable counts of cecal bifidobacteria., in J Nutr, vol. 141, n. 1, gennaio 2011, pp. 101-7, DOI:10.3945/jn.110.122226, PMID 21106924.
VT. Do, BG. Baird; DR. Kockler, Probiotics for maintaining remission of ulcerative colitis in adults., in Ann Pharmacother, vol. 44, n. 3, marzo 2010, pp. 565-71, DOI:10.1345/aph.1M498, PMID 20124461.
D. Heilpern, A. Szilagyi, Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics., in Rev Recent Clin Trials, vol. 3, n. 3, settembre 2008, pp. 167-84, PMID 18782075.
MP. Gosselink, WR. Schouten; LM. van Lieshout; WC. Hop; JD. Laman; JG. Ruseler-van Embden, Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG., in Dis Colon Rectum, vol. 47, n. 6, giugno 2004, pp. 876-84, DOI:10.1007/s10350-004-0525-z, PMID 15108026.
FK. Ghishan, PR. Kiela, From probiotics to therapeutics: another step forward?, in J Clin Invest, vol. 121, n. 6, giugno 2011, pp. 2149-52, DOI:10.1172/JCI58025, PMID 21606604.
TS. Plantinga, WW. van Maren; J. van Bergenhenegouwen; M. Hameetman; S. Nierkens; C. Jacobs; DJ. de Jong; LA. Joosten; B. van't Land; J. Garssen; GJ. Adema, Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics., in Clin Vaccine Immunol, vol. 18, n. 4, aprile 2011, pp. 621-8, DOI:10.1128/CVI.00498-10, PMID 21288993.
KA. Donato, MG. Gareau; YJ. Wang; PM. Sherman, Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling., in Microbiology, vol. 156, Pt 11, novembre 2010, pp. 3288-97, DOI:10.1099/mic.0.040139-0, PMID 20656777.
AJ. Martins, P. Colquhoun; G. Reid; SO. Kim, Reduced expression of basal and probiotic-inducible G-CSF in intestinal mononuclear cells is associated with inflammatory bowel disease., in Inflamm Bowel Dis, vol. 15, n. 4, aprile 2009, pp. 515-25, DOI:10.1002/ibd.20808, PMID 19058228.
BR. Goldin, SL. Gorbach, Clinical indications for probiotics: an overview., in Clin Infect Dis, 46 Suppl 2, febbraio 2008, pp. S96-100; discussion S144-51, DOI:10.1086/523333, PMID 18181732.
M Del Piano e altri, The innovative potential of Lactobacillus rhamnosus LR06, Lactobacillus pentosus LPS01, Lactobacillus plantarum LP01, and Lactobacillus delbrueckii Subsp. delbrueckii LDD01 to restore the "gastric barrier effect" in patients chronically treated with PPI: a pilot study, in J Clin Gastroenterol, n. 46, DOI:10.1097/MCG.0b013e318267b55d, PMID 22955351.
Roberto Berni Canani, Pia Cirillo e Gianluca Terrin, Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations, in BMJ (Clinical research ed.), vol. 335, n. 7615, 18 agosto 2007, p. 340, DOI:10.1136/bmj.39272.581736.55, PMID 17690340. URL consultato il 17 maggio 2018.
P. Osterlund, T. Ruotsalainen e R. Korpela, Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study, in British Journal of Cancer, vol. 97, n. 8, 22 ottobre 2007, pp. 1028-1034, DOI:10.1038/sj.bjc.6603990, PMID 17895895. URL consultato il 17 maggio 2018.
S. Guandalini, L. Pensabene e M. A. Zikri, Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial, in Journal of Pediatric Gastroenterology and Nutrition, vol. 30, n. 1, gennaio 2000, pp. 54-60, PMID 10630440. URL consultato il 17 maggio 2018.
Iva Hojsak, Valentina Fabiano e Tudor Lucian Pop, Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups, in Acta Paediatrica (Oslo, Norway: 1992), vol. 107, n. 6, 2018-6, pp. 927-937, DOI:10.1111/apa.14270, PMID 29446865. URL consultato il 17 maggio 2018.
Donald Cameron, Quak Seng Hock e Musal Kadim, Probiotics for gastrointestinal disorders: Proposed recommendations for children of the Asia-Pacific region, in World Journal of Gastroenterology, vol. 23, n. 45, 7 dicembre 2017, pp. 7952-7964, DOI:10.3748/wjg.v23.i45.7952, PMID 29259371. URL consultato il 17 maggio 2018.
Sara Blaabjerg, Daniel Maribo Artzi e Rune Aabenhus, Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients-A Systematic Review and Meta-Analysis, in Antibiotics (Basel, Switzerland), vol. 6, n. 4, 12 ottobre 2017, DOI:10.3390/antibiotics6040021, PMID 29023420. URL consultato il 17 maggio 2018.
Saif Ul Islam, Clinical Uses of Probiotics, in Medicine, vol. 95, n. 5, 2016-2, pp. e2658, DOI:10.1097/MD.0000000000002658, PMID 26844491. URL consultato il 17 maggio 2018.
R. J. Boyle, F. J. Bath-Hextall e J. Leonardi-Bee, Probiotics for the treatment of eczema: a systematic review, in Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology, vol. 39, n. 8, 2009-8, pp. 1117-1127, DOI:10.1111/j.1365-2222.2009.03305.x. URL consultato il 17 maggio 2018.
Marko Kalliomäki, Seppo Salminen e Tuija Poussa, Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial, in The Journal of Allergy and Clinical Immunology, vol. 119, n. 4, 2007-4, pp. 1019-1021, DOI:10.1016/j.jaci.2006.12.608. URL consultato il 17 maggio 2018.
M. Kalliomäki, S. Salminen e H. Arvilommi, Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial, in Lancet (London, England), vol. 357, n. 9262, 7 aprile 2001, pp. 1076-1079, DOI:10.1016/S0140-6736(00)04259-8, PMID 11297958.
A. Avlami, T. Kordossis e N. Vrizidis, Lactobacillus rhamnosus endocarditis complicating colonoscopy, in The Journal of Infection, vol. 42, n. 4, 2001-5, pp. 283-285, DOI:10.1053/jinf.2001.0793. URL consultato il 17 maggio 2018.
V. Gupta e R. Garg, Probiotics, in Indian Journal of Medical Microbiology, vol. 27, n. 3, 2009-7, pp. 202-209, DOI:10.4103/0255-0857.53201, PMID 19584499. URL consultato il 17 maggio 2018.
Minna K. Salminen, Soile Tynkkynen e Hilpi Rautelin, Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland, in Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, vol. 35, n. 10, 15 novembre 2002, pp. 1155-1160, DOI:10.1086/342912. URL consultato il 17 maggio 2018.

oadoi.org

IJ. Claes, G. Schoofs; K. Regulski; P. Courtin; MP. Chapot-Chartier; T. Rolain; P. Hols; I. von Ossowski; J. Reunanen; WM. de Vos; A. Palva, Genetic and biochemical characterization of the cell wall hydrolase activity of the major secreted protein of Lactobacillus rhamnosus GG., in PLoS One, vol. 7, n. 2, 2012, pp. e31588, DOI:10.1371/journal.pone.0031588, PMID 22359601.
R. Korhonen, O. Kosonen; R. Korpela; E. Moilanen, The expression of COX2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells., in Lett Appl Microbiol, vol. 39, n. 1, 2004, pp. 19-24, DOI:10.1111/j.1472-765X.2004.01531.x, PMID 15189283.
A. Klinder, A. Förster; G. Caderni; AP. Femia; BL. Pool-Zobel, Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination., in Nutr Cancer, vol. 49, n. 2, 2004, pp. 144-55, DOI:10.1207/s15327914nc4902_5, PMID 15489207.
M. Lorea Baroja, PV. Kirjavainen; S. Hekmat; G. Reid, Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients., in Clin Exp Immunol, vol. 149, n. 3, settembre 2007, pp. 470-9, DOI:10.1111/j.1365-2249.2007.03434.x, PMID 17590176.
B. Foligne, G. Zoumpopoulou; J. Dewulf; A. Ben Younes; F. Chareyre; JC. Sirard; B. Pot; C. Grangette, A key role of dendritic cells in probiotic functionality., in PLoS One, vol. 2, n. 3, 2007, pp. e313, DOI:10.1371/journal.pone.0000313, PMID 17375199.
A. Pillai, R. Nelson, Probiotics for treatment of Clostridium difficile-associated colitis in adults., in Cochrane Database Syst Rev, n. 1, 2008, pp. CD004611, DOI:10.1002/14651858.CD004611.pub2, PMID 18254055.
PW. Lin, LE. Myers; L. Ray; SC. Song; TR. Nasr; AJ. Berardinelli; K. Kundu; N. Murthy; JM. Hansen; AS. Neish, Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation., in Free Radic Biol Med, vol. 47, n. 8, ottobre 2009, pp. 1205-11, DOI:10.1016/j.freeradbiomed.2009.07.033, PMID 19660542.
E. Mileti, G. Matteoli; ID. Iliev; M. Rescigno, Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy., in PLoS One, vol. 4, n. 9, 2009, pp. e7056, DOI:10.1371/journal.pone.0007056, PMID 19756155.
IJ. Claes, S. Lebeer; C. Shen; TL. Verhoeven; E. Dilissen; G. De Hertogh; DM. Bullens; JL. Ceuppens; G. Van Assche; S. Vermeire; P. Rutgeerts, Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis., in Clin Exp Immunol, vol. 162, n. 2, novembre 2010, pp. 306-14, DOI:10.1111/j.1365-2249.2010.04228.x, PMID 20731672.
D. Jonkers, J. Penders; A. Masclee; M. Pierik, Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients., in Drugs, vol. 72, n. 6, aprile 2012, pp. 803-23, DOI:10.2165/11632710-000000000-00000, PMID 22512365.
FK. Ghishan, PR. Kiela, From probiotics to therapeutics: another step forward?, in J Clin Invest, vol. 121, n. 6, giugno 2011, pp. 2149-52, DOI:10.1172/JCI58025, PMID 21606604.
TS. Plantinga, WW. van Maren; J. van Bergenhenegouwen; M. Hameetman; S. Nierkens; C. Jacobs; DJ. de Jong; LA. Joosten; B. van't Land; J. Garssen; GJ. Adema, Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics., in Clin Vaccine Immunol, vol. 18, n. 4, aprile 2011, pp. 621-8, DOI:10.1128/CVI.00498-10, PMID 21288993.
KA. Donato, MG. Gareau; YJ. Wang; PM. Sherman, Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling., in Microbiology, vol. 156, Pt 11, novembre 2010, pp. 3288-97, DOI:10.1099/mic.0.040139-0, PMID 20656777.
AJ. Martins, P. Colquhoun; G. Reid; SO. Kim, Reduced expression of basal and probiotic-inducible G-CSF in intestinal mononuclear cells is associated with inflammatory bowel disease., in Inflamm Bowel Dis, vol. 15, n. 4, aprile 2009, pp. 515-25, DOI:10.1002/ibd.20808, PMID 19058228.
BR. Goldin, SL. Gorbach, Clinical indications for probiotics: an overview., in Clin Infect Dis, 46 Suppl 2, febbraio 2008, pp. S96-100; discussion S144-51, DOI:10.1086/523333, PMID 18181732.